References
- Nawrocki S, Cha J. The etiology, diagnosis, and management of hyperhidrosis: a comprehensive review: etiology and clinical work-up. J Am Acad Dermatol. 2019;81(3):657–666.
- Lenefsky M, Rice ZP. Hyperhidrosis and its impact on those living with it. Am J Manag Care. 2018;24(23):S491–S495.
- Doolittle J, Walker P, Mills T, et al. Hyperhidrosis: an update on prevalence and severity in the United States. Arch Dermatol Res. 2016;308(10):743–749.
- Grabell DA, Hebert AA. Current and emerging medical therapies for primary hyperhidrosis. Dermatol Ther (Heidelb). 2017;7(1):25–36.
- Augustin M, Radtke MA, Herberger K, et al. Prevalence and disease burden of hyperhidrosis in the adult population. Dermatology. 2013;227(1):10–13.
- McConaghy JR, Fosselman D. Hyperhidrosis: management options. Am Fam Physician. 2018;97(11):729–734.
- Schollhammer M, Brenaut E, Menard-Andivot N, et al. Oxybutynin as a treatment for generalized hyperhidrosis: a randomized, placebo-controlled trial. Br J Dermatol. 2015;173(5):1163–1168.
- Zarrabi AJ, Frediani JK, Levy JM. The state of cannabis research legislation in 2020. N Engl J Med. 2020;382(20):1876–1877.
- Friedman D, French JA, Maccarrone M. Safety, efficacy, and mechanisms of action of cannabinoids in neurological disorders. Lancet Neurol. 2019;18(5):504–512.
- Chaboya-Hembree J. Palmar hyperhydrosis and medical marijuana. 2021. [cited 06 September 2021]. Available from: https://www.medicalmarijuana.com/medical-marijuana-treatments-cannabis-uses/palmar-hyperhydrosis-and-medical-mrijuana/
- Maida V. Nabilone for the treatment of paraneoplastic night sweats: a report of four cases. J Palliat Med. 2008;11(6):929–934.
- Carr C, Vertelney H, Fronk J, et al. Dronabinol for the treatment of paraneoplastic night sweats in cancer patients: a report of five cases. J Palliat Med. 2019;22(10):1221–1223.
- Bovell DL, Clunes MT, Elder HY, et al. Ultrastructure of the hyperhidrotic eccrine sweat gland. Br J Dermatol. 2001;145(2):298–301.